ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances?

April 21, 1995

In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela

November 7, 1997

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Creating the Modern Cancer Center

November 2, 2021